Citigroup’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-973,604
| Closed | -$18.4M | – | 5332 |
|
|
2019
Q3 | $18.4M | Buy |
973,604
+737,892
| +313% | +$13.9M | 0.01% | 555 |
|
|
2019
Q2 | $2.77M | Buy |
235,712
+217,638
| +1,204% | +$2.56M | ﹤0.01% | 1429 |
|
|
2019
Q1 | $247K | Sell |
18,074
-313,862
| -95% | -$4.29M | ﹤0.01% | 2992 |
|
|
2018
Q4 | $3.4M | Buy |
331,936
+200,294
| +152% | +$2.05M | ﹤0.01% | 1231 |
|
|
2018
Q3 | $2.19M | Buy |
131,642
+109,843
| +504% | +$1.83M | ﹤0.01% | 1450 |
|
|
2018
Q2 | $345K | Sell |
21,799
-31,373
| -59% | -$497K | ﹤0.01% | 2579 |
|
|
2018
Q1 | $675K | Sell |
53,172
-66,378
| -56% | -$843K | ﹤0.01% | 2101 |
|
|
2017
Q4 | $1.37M | Sell |
119,550
-5,570
| -4% | -$63.8K | ﹤0.01% | 1692 |
|
|
2017
Q3 | $1.53M | Buy |
125,120
+91,687
| +274% | +$1.12M | ﹤0.01% | 1654 |
|
|
2017
Q2 | $383K | Buy |
33,433
+24,765
| +286% | +$284K | ﹤0.01% | 2581 |
|
|
2017
Q1 | $180K | Sell |
8,668
-114,287
| -93% | -$2.37M | ﹤0.01% | 3030 |
|
|
2016
Q4 | $2.56M | Buy |
122,955
+106,792
| +661% | +$2.22M | ﹤0.01% | 1621 |
|
|
2016
Q3 | $530K | Buy |
16,163
+6,244
| +63% | +$205K | ﹤0.01% | 2400 |
|
|
2016
Q2 | $248K | Sell |
9,919
-11,714
| -54% | -$293K | ﹤0.01% | 2710 |
|
|
2016
Q1 | $530K | Buy |
21,633
+15,148
| +234% | +$371K | ﹤0.01% | 2635 |
|
|
2015
Q4 | $215K | Sell |
6,485
-14,841
| -70% | -$492K | ﹤0.01% | 3002 |
|
|
2015
Q3 | $699K | Buy |
21,326
+13,944
| +189% | +$457K | ﹤0.01% | 1974 |
|
|
2015
Q2 | $391K | Buy |
7,382
+1,397
| +23% | +$74K | ﹤0.01% | 2328 |
|
|
2015
Q1 | $172K | Sell |
5,985
-1,832
| -23% | -$52.6K | ﹤0.01% | 3068 |
|
|
2014
Q4 | $227K | Sell |
7,817
-60,280
| -89% | -$1.75M | ﹤0.01% | 3056 |
|
|
2014
Q3 | $863K | Buy |
68,097
+68,029
| +100,043% | +$862K | ﹤0.01% | 1683 |
|
|
2014
Q2 | $1K | Buy |
+68
| New | +$1K | ﹤0.01% | 5365 |
|